Significant improvement in BI at M3 with a positive trend close to statistical significance at M6 suggests the potential use of MLC601 in moderate TBI.
← all excerpts
Clinical Outcomes of MLC601 (NeuroAiD<sup>TM</sup>) in Traumatic Brain Injury: A Pilot Study.
1
—
—